Related Experiment Videos
Bentall operation with valved homograft conduit
S K Choudhary1, S Talwar, A S Kumar
1Department of Cardiothoracic and Vascular Surgery, All India Institute of Medical Sciences, Ansari Nagar, New Delhi.
Texas Heart Institute Journal
|February 24, 2001
Summary
The Bentall procedure using cryopreserved homograft conduits is a safe and effective treatment for ascending aorta lesions and aortic valve disease. This approach demonstrated excellent valve function and conduit integrity in a small patient cohort.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Aortic Valve Disease
Background:
- Ascending aorta lesions with aortic valve disease typically require prosthetic valved conduits via the Bentall procedure.
- Limited data exists on the use of homograft conduits in this complex surgical scenario.
Purpose of the Study:
- To evaluate the safety and efficacy of using cryopreserved valved homograft conduits in the Bentall procedure.
- To assess the short- and medium-term outcomes of this surgical technique.
Main Methods:
- Six patients underwent the Bentall procedure using cryopreserved valved homograft conduits (aortic or pulmonary).
- Procedures involved moderate hypothermia, cardiopulmonary bypass, and direct coronary ostia anastomosis.
- Echocardiography and MRI were used for postoperative and long-term follow-up.
Main Results:
- All patients exhibited good valve function and no homograft conduit dilatation on echocardiography.
- One late death occurred due to endocarditis; MRI showed normal conduit caliber at 24 months.
- The procedure was technically successful in all cases.
Conclusions:
- The Bentall procedure with cryopreserved homograft conduits is a safe and effective option for treating ascending aorta pathologies.
- Excellent short- and medium-term results support the use of homografts in this context.